Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anna S. Deal"'
Publikováno v:
Lower Urinary Tract Symptoms
Objectives This analysis from the PERSPECTIVE (a Prospective, Non‐interventional Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder) study evaluated treatment persistence with mirabegron or antimuscarinics over a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d81cb3dea2451535bfa51726e6a75f
https://doi.org/10.1111/luts.12382
https://doi.org/10.1111/luts.12382
Autor:
Anna S. Deal, Kevin V. Carlson, Rita M Kristy, Eric S. Rovner, Carol R. Schermer, Kavita V. Nair
Publikováno v:
Advances in Therapy
Introduction Patient-reported outcomes (PROs) provide valuable insights about the effectiveness of overactive bladder (OAB) treatments. The aim of PERSPECTIVE (a Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c3b2f00253d166e2e965e36cc1ad0f
http://europepmc.org/articles/PMC6822866
http://europepmc.org/articles/PMC6822866
Autor:
Carol R. Schermer, Katherine Gooch, Anna S. Deal, Kavita V. Nair, Eric S. Rovner, Eric Gemmen, Julie Park, Kevin V. Carlson, Eva Erber Oakkar, Rita M Kristy
Publikováno v:
Contemporary clinical trials. 70
Introduction Pharmacotherapy of overactive bladder (OAB) typically involves treatment with an antimuscarinic or mirabegron, a β3-adrenoceptor agonist, but real-world evidence on their use, including treatment access, persistence, and switching, is l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3d41780c11438b0ef65439ad9fcbac6
https://pubmed.ncbi.nlm.nih.gov/29777865
https://pubmed.ncbi.nlm.nih.gov/29777865